US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 18.650
  • +0.880+4.95%
Trading Nov 22 14:13 ET
1.01BMarket Cap-17063P/E (TTM)

Bicara Therapeutics Key Stats

Bicara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

Bicara Therapeutics Earnings Reports

Analysis

Analyst Rating

Updated: Nov 13, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data